TY - JOUR
T1 - Applications of monoclonal antibodies and recombinant cytokines for the treatment of human colorectal and other carcinomas.
AU - Greiner, J. W.
AU - Smalley, R. V.
AU - Borden, E. C.
AU - Martin, E. W.
AU - Guadagni, F.
AU - Roselli, M.
AU - Schlom, J.
PY - 1991
Y1 - 1991
N2 - Monoclonal antibodies (MAbs) which recognize a human tumor antigen, termed tumor-associated glycoprotein-72 (TAG-72), have successfully been used to localize primary as well as metastatic colorectal tumor lesions in patients. The localization of the anti-TAG-72 MAbs has also been exploited intraoperatively using a hand-held gamma probe. That procedure, termed radioimmunoguided surgery (RIGS), has identified occult tumors which were not detected using standard external imaging techniques. In another clinical trial, interferon-gamma (IFN-gamma) was administered intraperitoneally to patients diagnosed with either gastrointestinal or ovarian carcinoma with secondary ascites. Analysis of the tumor cells isolated from the malignant ascites revealed a substantial increase in TAG-72 expression on the surface of tumor cells isolated from seven of eight patients. The results provide evidence that the combination of an anti-carcinoma MAb with the administration of a cytokine, such as IFN-gamma, may be an effective approach for the detection and subsequent treatment, of colorectal carcinoma.
AB - Monoclonal antibodies (MAbs) which recognize a human tumor antigen, termed tumor-associated glycoprotein-72 (TAG-72), have successfully been used to localize primary as well as metastatic colorectal tumor lesions in patients. The localization of the anti-TAG-72 MAbs has also been exploited intraoperatively using a hand-held gamma probe. That procedure, termed radioimmunoguided surgery (RIGS), has identified occult tumors which were not detected using standard external imaging techniques. In another clinical trial, interferon-gamma (IFN-gamma) was administered intraperitoneally to patients diagnosed with either gastrointestinal or ovarian carcinoma with secondary ascites. Analysis of the tumor cells isolated from the malignant ascites revealed a substantial increase in TAG-72 expression on the surface of tumor cells isolated from seven of eight patients. The results provide evidence that the combination of an anti-carcinoma MAb with the administration of a cytokine, such as IFN-gamma, may be an effective approach for the detection and subsequent treatment, of colorectal carcinoma.
UR - http://www.scopus.com/inward/record.url?scp=0025997322&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025997322&partnerID=8YFLogxK
M3 - Article
C2 - 1909869
AN - SCOPUS:0025997322
VL - 2
SP - 9
EP - 13
JO - Journal of surgical oncology. Supplement
JF - Journal of surgical oncology. Supplement
SN - 1046-7416
ER -